News tagged with infliximab
Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients
Oct 29, 2009 |
not rated yet |
0
A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. The research team, ...
Biologics for rheumatoid arthritis work, but which is best?
Oct 07, 2009 |
3.5 / 5 (2) |
0
More studies that directly compare the effectiveness of different biologic drugs for rheumatoid arthritis (RA) are needed, say Cochrane Researchers. The researchers reviewed all previous Cochrane Systematic Reviews assessing ...
Ulcerative colitis treatment reduces need for surgery by almost half
Oct 01, 2009 |
5 / 5 (1) |
0
A new study led by Mayo Clinic researchers has found that ulcerative colitis patients had a 41 percent reduction in colectomy after a year when treated with infliximab, according to a study published in the October 2009 issue ...
Risk of tuberculosis from arthritis medication examined
Jun 30, 2009 |
1.5 / 5 (2) |
0
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's ...
Cost shifting may make arthritis medications too expensive for medicare beneficiaries
Jun 01, 2009 |
5 / 5 (1) |
0
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, ...
Infliximab may help prevent post-operative Crohn's disease recurrence
Feb 01, 2009 |
not rated yet |
0
The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official ...
